News Agency
The Times

Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030

  • Written by PR Newswire
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030
  • Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36th new drug from the Ministry of Food and Drug Safety
  • Plans to enter the type 2 diabetes global market worth $71.4 billion
  • Provides new and broad treatment options for patients with insufficient blood glucose control with three indications

SEOUL, South Korea...

Read more: Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion